Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-15.17	40.40	47.63
Graham Fair Price	-22.67	15.24	19.71
PEG	-117.57	-0.39	-0.18
Price/Book	21.71	4.30	3.53
Price/Cash Flow	-98.99	57.14	-5648.79
Prices/Earnings	97.31	15.39	7.80
Price/Sales	18.67	10.51	8.86
Price/FCF	-98.99	57.14	-5648.79
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.28	0.73	0.72
Operating Margin	45.10	0.29	0.20
ROA	-38.93	0.02	0.03
ROE	0.11	0.07	-38.32
ROIC	0.03	0.04	70.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-86.91
Dividends QOQ	< 0.005	0.08	4037.80
EBIT QOQ	0.11	0.46	302.12
EPS QOQ	-0.43	-0.39	9.31
FCF QOQ	-1.01	119.00	11739.05
Revenue QOQ	0.02	< 0.005	-71.18
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	42.55	45.39	6.67
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.55	0.56	0.90
Quick Ratio	2.26	1.81	-19.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.35	12.16	-1.54
Cash	17.40	15.88	-8.78
Capex	-0.24	-0.28	-13.93
Free Cash Flow	< 0.005	0.91	11745.74
Revenue	4.92	4.97	0.98
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.44	1.99	-18.41
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.28	7.35	-28.49
Naive Interpretation	Member

06 - Financial Health · Weak

Rating